Variant report
Variant | esv3378727 |
---|---|
Chromosome Location | chr21:39964137-39964474 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr21:39952017..39953838-chr21:39962654..39965463,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs541358423 | chr21:39964179-39964180 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs973105 | chr21:39964199-39964200 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs530051459 | chr21:39964212-39964213 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs543754110 | chr21:39964218-39964219 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs3065417 | chr21:39964281-39964282 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs397867446 | chr21:39964283-39964284 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs2836545 | chr21:39964298-39964299 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs146631953 | chr21:39964352-39964353 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs186688266 | chr21:39964357-39964358 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs34518799 | chr21:39964366-39964367 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs140045436 | chr21:39964371-39964372 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs9976134 | chr21:39964375-39964376 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs35943698 | chr21:39964386-39964387 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs60212067 | chr21:39964402-39964403 | Bivalent Enhancer Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs192444789 | chr21:39964441-39964442 | Bivalent Enhancer Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs183438230 | chr21:39964456-39964457 | Bivalent Enhancer Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs370966217 | chr21:39964467-39964468 | Bivalent Enhancer Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Down syndrome | 17412756 | CNVD |
Down syndrome | 17576883 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Seminomas | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Prostate cancer | 19156837 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Melanoma | 18172304 | CNVD |
Autism | 22958593 | CNVD |
Schizophrenia | 22958593 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Wilms tumour | 21544195 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Mental retardation | 21031080 | CNVD |
Polymicrogyria | 21031080 | CNVD |
periventricular nodular heterotopia | 21031080 | CNVD |
Myelodysplastic syndrome | 21606161 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Acute myeloid leukemia | 17237825 | CNVD |
Autism | 18414403 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Breast cancer | 21858162 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 17899364 | CNVD |
Down syndrome | 20877625 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cancer | 20164920 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Prostate cancer | 21147910 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Prostate cancer | 17245344 | CNVD |
Prostate cancer | 20473283 | CNVD |
Chordoma | 18071362 | CNVD |
Prostate cancer | 20562851 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr21:39955800-39971200 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
2 | chr21:39956600-39966000 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
3 | chr21:39961800-39964200 | Weak transcription | Aorta | Aorta |
4 | chr21:39963800-39964400 | Enhancers | Fetal Muscle Leg | muscle |
5 | chr21:39964000-39964400 | Enhancers | Fetal Muscle Trunk | muscle |
6 | chr21:39964000-39964400 | Enhancers | Spleen | Spleen |
7 | chr21:39964200-39964600 | Enhancers | Aorta | Aorta |
8 | chr21:39964200-39964800 | Enhancers | Fetal Brain Female | brain |
9 | chr21:39964400-39964800 | Bivalent Enhancer | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
10 | chr21:39964400-39965000 | Bivalent Enhancer | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
11 | chr21:39964400-39968800 | Weak transcription | Spleen | Spleen |